TSE Health Center

Pierre Dubois, Gosia Majewska, and Valentina Reig, “Drug Shortages: Empirical Evidence from France”, TSE Working Paper, n. 23-1417, March 2023.

Pierre Dubois, and Thierry Magnac, “Optimal Intertemporal Curative Drug Expenses: The Case of Hepatitis C in France”, TSE Working Paper, n. 23-1402, January 2023.

Ilaria Natali, Mathias Dewatripont, Victor Ginsburgh, Michel Goldman, and Patrick Legros, “Prescription Opioids and Economic Hardship in France”, TSE Working Paper, n. 22-1388, December 2022.

Pierre Dubois, Paul-Henri Moisson, and Jean Tirole, “The Economics of Transferable Patent Extensions”, TSE Working Paper, n. 22-1377, November 2022, revised December 2022.

Pierre Dubois, and Gosia Majewska, “Mergers and Advertising in the Pharmaceutical Industry”, TSE Working Paper, n. 22-1380, October 2022.

Tuba Tuncel, “Should We Prevent Off-Label Drug Prescriptions? Empirical Evidence from France”, TSE Working Paper, n. 22-1383, September 2022.

James K. Hammitt, “Downside Risk Aversion vs Decreasing Absolute Risk Aversion: An Intuitive Exposition”, TSE Working Paper, n. 22-1359, September 2022.

Chiara Canta, and Helmuth Cremer, “Family bargaining and the gender gap in informal care”, TSE Working Paper, n. 2022-1352, August 2022.

Philippe De Donder, Marie-Louise Leroux, and François Salanié, “Advantageous selection without moral hazard (with an application to life care annuities)”, TSE Working Paper, n. 22-1334, May 2022.

James K. Hammitt, “Prevention, Treatment, and Palliative Care: The Relative Value of Health Improvements under Alternative Evaluation Frameworks”, TSE Working Paper, n. 22-1339, May 2022.